A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 283.1-283
◽
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 824.1-824
2013 ◽
Vol 73
(1)
◽
pp. 101-107
◽
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 719.2-719
Keyword(s):
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A87.2-A88
◽